174 related articles for article (PubMed ID: 20076888)
21. IgM anticardiolipin antibodies are associated with stenosis of vascular access in hemodialysis patients but do not predict thrombosis.
Adler S; Szczech L; Qureshi A; Bollu R; Thomas-John R
Clin Nephrol; 2001 Dec; 56(6):428-34. PubMed ID: 11770794
[TBL] [Abstract][Full Text] [Related]
22. A Comparitive Study of Anticardiolipin Antibodies among Systemic Lupus Erythematosus Patients from Western and Eastern India.
Doley D; Kakati S; Saikia L; Rajadhyaksha A; Nadkar M; Khadilkar P; Patwardhan M; Pradhan V
J Assoc Physicians India; 2017 Mar; 65(3):14-19. PubMed ID: 28462538
[TBL] [Abstract][Full Text] [Related]
23. The relationship between anticardiolipin antibodies and vascular access occlusion in patients on hemodialysis.
Gültekin F; Alagözlü H; Candan F; Nadir I; Bakici MZ; Sezer H
ASAIO J; 2005; 51(2):162-4. PubMed ID: 15839442
[TBL] [Abstract][Full Text] [Related]
24. Elevated serum antiphospholipid antibodies in adults with celiac disease.
Laine O; Pitkänen K; Lindfors K; Huhtala H; Niemelä O; Collin P; Kurppa K; Kaukinen K
Dig Liver Dis; 2018 May; 50(5):457-461. PubMed ID: 29258815
[TBL] [Abstract][Full Text] [Related]
25. Anticardiolipin antibodies: clinical consequences of "low titers".
Silver RM; Porter TF; van Leeuween I; Jeng G; Scott JR; Branch DW
Obstet Gynecol; 1996 Apr; 87(4):494-500. PubMed ID: 8602297
[TBL] [Abstract][Full Text] [Related]
26. Prevalence and signification of antinuclear and anticardiolipin antibodies in patients with epilepsy.
Verrot D; San-Marco M; Dravet C; Genton P; Disdier P; Bolla G; Harle JR; Reynaud L; Weiller PJ
Am J Med; 1997 Jul; 103(1):33-7. PubMed ID: 9236483
[TBL] [Abstract][Full Text] [Related]
27. The course of anticardiolipin antibody levels under immunoadsorption therapy.
Hauser AC; Hauser L; Pabinger-Fasching I; Quehenberger P; Derfler K; Hörl WH
Am J Kidney Dis; 2005 Sep; 46(3):446-54. PubMed ID: 16129206
[TBL] [Abstract][Full Text] [Related]
28. Evidence that anticardiolipin antibodies are independent risk factors for atherosclerotic vascular disease.
Glueck CJ; Lang JE; Tracy T; Sieve-Smith L; Wang P
Am J Cardiol; 1999 May; 83(10):1490-4, A8. PubMed ID: 10335769
[TBL] [Abstract][Full Text] [Related]
29. Anticardiolipin antibodies and the risk for ischemic stroke and venous thrombosis.
Ginsburg KS; Liang MH; Newcomer L; Goldhaber SZ; Schur PH; Hennekens CH; Stampfer MJ
Ann Intern Med; 1992 Dec; 117(12):997-1002. PubMed ID: 1443986
[TBL] [Abstract][Full Text] [Related]
30. Buerger's disease and anticardiolipin antibodies.
Pereira de Godoy JM; Braile DM
J Cardiovasc Med (Hagerstown); 2009 Oct; 10(10):792-4. PubMed ID: 19455050
[TBL] [Abstract][Full Text] [Related]
31. Anticardiolipin antibodies in children with insulin-dependent diabetes mellitus.
Mohamed SM; Abdou MO; Assem HM; Moustafa TM; Soghier LM
Metabolism; 2002 Sep; 51(9):1148-52. PubMed ID: 12200759
[TBL] [Abstract][Full Text] [Related]
32. Anticardiolipin antibodies and osteonecrosis of the femoral head.
Korompilias AV; Gilkeson GS; Ortel TL; Seaber AV; Urbaniak JR
Clin Orthop Relat Res; 1997 Dec; (345):174-80. PubMed ID: 9418637
[TBL] [Abstract][Full Text] [Related]
33. Accuracy of anticardiolipin antibodies in identifying a history of thrombosis among patients with systemic lupus erythematosus.
Escalante A; Brey RL; Mitchell BD; Dreiner U
Am J Med; 1995 Jun; 98(6):559-65. PubMed ID: 7778571
[TBL] [Abstract][Full Text] [Related]
34. [Anticardiolipin antibodies in hemodialysis patients and in renal transplant recipients: prevalence and significance].
Ferlazzo B; Barrile A; Bonanno D; Quattrocchi P; Santoro D; Savica V; Bellinghieri G
Recenti Prog Med; 1998 Sep; 89(9):434-7. PubMed ID: 9796372
[TBL] [Abstract][Full Text] [Related]
35. Prevalence of antiphospholipid and antioxidized low-density lipoprotein antibodies in rheumatoid arthritis.
Sherer Y; Gerli R; Vaudo G; Schillaci G; Gilburd B; Giordano A; Bocci EB; Allegrucci R; Marchesi S; Mannarino E; Shoenfeld Y
Ann N Y Acad Sci; 2005 Jun; 1051():299-303. PubMed ID: 16126971
[TBL] [Abstract][Full Text] [Related]
36. Activated protein C resistance and anticardiolipin antibodies in patients with venous leg ulcers.
Fisher DA
J Am Acad Dermatol; 1998 Aug; 39(2 Pt 1):299-300. PubMed ID: 9704858
[No Abstract] [Full Text] [Related]
37. Anticardiolipin and antinuclear antibodies in the adult healthy Omani individuals.
Al Jabri AA; Al Buloshi MS
Saudi Med J; 2004 Mar; 25(3):313-7. PubMed ID: 15048168
[TBL] [Abstract][Full Text] [Related]
38. Anticardiolipin antibodies during hormone replacement therapy in healthy postmenopausal women.
Todorova M; Kamenov Z; Baleva M; Christov V; Nicolov K
Maturitas; 2004 Aug; 48(4):393-7. PubMed ID: 15283931
[TBL] [Abstract][Full Text] [Related]
39. Thromboembolic risk in patients with high titre anticardiolipin and multiple antiphospholipid antibodies.
Neville C; Rauch J; Kassis J; Chang ER; Joseph L; Le Comte M; Fortin PR
Thromb Haemost; 2003 Jul; 90(1):108-15. PubMed ID: 12876633
[TBL] [Abstract][Full Text] [Related]
40. [Anticardiolipin antibodies and early infarct of the myocardium].
Gaeta G; Lupoli S; Brancaccio V; Effuso L; Russo V; Boccalatte A
Cardiologia; 1998 Jul; 43(7):731-5. PubMed ID: 9738331
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
